Clonidine assay

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

23230B, 260112R, 424 12, 424251, 544264, G01N 3316, A61K 4300, C07G 700, A61K 3900

Patent

active

040949648

ABSTRACT:
A sensitive immunoassay for clonidine, 2-(2,6-dichloroanilino)-2-imidazoline hydrochloride is described. To prepare the clonidine selective antiserum, an antigen is made comprising 4-[[6-[2,4-dichloro-3(4,5-dihydro-1H-imidazol-2-yl)amino]hydroxyphenyl]azo ]benzoic acid covalently bonded to an immunogenic carrier material through a peptide bond formed from said carboxyl group and amino groups contained in said immunogenic carrier material and the antigen is injected into a suitable host animal to elicit the desired antiserum.

REFERENCES:
frydman, Chemical Abstracts, vol. 84, No. 9, Mar. 1, 1976, p. 5, Abstract No. 53715c.
Rouot et al., Chemical Abstracts, vol. 85, No. 9, Aug. 30, 1976, p. 17, Abstract No. 56532x.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Clonidine assay does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Clonidine assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clonidine assay will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-10135

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.